Despite efforts for improvement, the "State of the Air" report reveals concerns.

Published Date: 23 Apr 2023

Despite Improvement Efforts, the "State of the Air" Report Highlights Issues.

Read Full News

Latest News

COPD and Heart Disease Demand Integrated Clinical Care

Failing to look beyond spirometry in COPD costs lives. Experts at ERS 2026 present new clinical guidance to unify cardiovascular and respiratory management.

Roivant's Experimental Lung Disease Drug Meets Goals in Mid-stage Study

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Shared Decision-Making in Pediatric Lung Care

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Advances in Care for Rare Pediatric Lung Diseases

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

US CDC Records More Than 3,100 Measles Cases So Far in 2026

The U.S. Centers for Disease Control and Prevention said on Friday there were 3,134 confirmed measles ⁠cases in the country so far this year, marking the highest annual...

Holistic Care Must Be Standard in Lung Disease

Experts at ERS 2026 urge clinicians to treat the whole person rather than just damaged lungs, moving from mere symptom control to focus on what matters most to each patient.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Latest News

Failing to look beyond spirometry in COPD costs lives. Experts at ERS 2026 present new clinical guidance to unify cardiovascular and respiratory management.

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

The U.S. Centers for Disease Control and Prevention said on Friday there were 3,134 confirmed measles ⁠cases in the country so far this year, marking the highest annual...

Experts at ERS 2026 urge clinicians to treat the whole person rather than just damaged lungs, moving from mere symptom control to focus on what matters most to each patient.

News All Time

FDA Greenlights Next-Generation ROS1 Inhibitor for Lung Cancer

Zidesamtinib is indicated for patients who received a prior ROS1 inhibitor

Reproductive Health Should Be Emphasized in Cystic Fibrosis Care, Foundation Says

Clinicians should initiate annual discussions

Novel Antifungal Shows Activity in Valley Fever

Three-quarters of patients had a clinical response in mid-stage study

CDC Suggests Threat of Mold-Associated Illnesses May Be Underappreciated

"It's kind of the first time we've had an estimate like this," the study's senior author says

FDA Approves First mRNA Flu Vaccine

Approval is for people 50 years or older
HTTP error: 503

Senators Pan Trump Officials' Demand for Health Data as Condition for Lifesaving Aid

"These new demands set an alarming precedent," Democratic senators noted
HTTP error: 503

Overheard in Medicine: Pandemic Wounds Reopened

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Tenax Heart Drug Fails to Improve Walking Results in Study, Shares Plunge

Tenax Therapeutics said on Monday its experimental drug did not significantly improve how far patients could walk compared with ⁠placebo in a late-stage trial for a...

Ivacaftor Boosts Height and Lung Function in Cystic Fibrosis

Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have improved height and lung capacity than peers who do not receive ivacaftor.

Housing Aid Linked to Better NSCLC Survival

Housing assistance was associated with lower mortality among older adults with NSCLC, but the survival advantage was not explained by differences in guideline-concordant treatment.

More Bronchiectasis Patients Benefit From HEMT

Data from the US Bronchiectasis and NTM Research Registry show improvements in cough and exacerbations with highly effective modulator therapy.

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Case Report: Paradoxical Bronchoconstriction with Short-Acting Beta Agonist

Clinicians perform pulmonary function tests to find the cause

Why Is a Fit Swimmer Breathless and Coughing Up Blood?

Case highlights a little-known, potentially dangerous, often recurrent condition of swimmers

Recommended News For You

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.

Clinical trial is testing whether heavy lifting could combat cancer side effects

Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again

FDA approves rivanetin as the first-line treatment for lung cancer.

Routine breast cancer screening can bring better outcomes for patients

Recommended Articles For You

Lymphomatoid Papulosis: What You Need to Know 

Critical Care Challenges in Oncologic Emergencies 

Emerging Therapies Using Immune-Engineered Cancer Eradication Platforms 

Clinical Frameworks in Oncology and Quality Improvement 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries

2.

EVP Beats Cisplatin for Resectable MIBC

3.

EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer

4.

Oncologist on Hantavirus Cruise; Bile Duct Cancer Drug OK'd; Untreated Lung Cancers

5.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

1.

Innovative Breakthroughs in Hematology for Modern Medicine

2.

Altered Marrow Cell-Production Dynamics During Chronic Hematologic Stress

3.

Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan

4.

Work Function in Hematologic Disease: Mechanisms, Clinical Implications, and Emerging Perspectives

5.

Adaptive Rehabilitation Frameworks for Complex Cancer Survivorship

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Should We Use DARA Up Front As First-Line Therapy in MM?

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

4.

Thromboprophylaxis In Medical Settings

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot